CONSOLIDATED INCOME STATEMENT - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues	$ 571,414	$ 556,389
Cost of service, inclusive of depreciation	321,537	315,010
General and administrative expenses:
Salaries and benefits	127,946	126,339
Non-cash compensation	7,433	3,273
Merger-related expenses	20,667	720
Depreciation and amortization	4,271	4,443
Other	57,941	64,225
Total operating expenses	539,795	514,010
Operating income	31,619	42,379
Other income (expense):
Interest income	1,727	406
Interest expense	(8,119)	(7,517)
Equity in earnings from equity method investments	910	123
Miscellaneous, net	1,090	(682)
Total other expense, net	(4,392)	(7,670)
Income before income taxes	27,227	34,709
Income tax expense	(12,633)	(9,800)
Net income	14,594	24,909
Net (income) loss attributable to noncontrolling interests	(194)	337
Net income attributable to Amedisys, Inc.	$ 14,400	$ 25,246
Basic earnings per common share:
Net income attributable to Amedisys, Inc. common stockholders	$ 0.44	$ 0.78
Weighted average shares outstanding, basic (shares)	32,670	32,558
Diluted earnings per common share:
Net income attributable to Amedisys, Inc. common stockholders	$ 0.44	$ 0.77
Weighted average shares outstanding, diluted (shares)	32,979	32,643